These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 11161980)

  • 1. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
    Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
    Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
    Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
    J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
    Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
    J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
    Cai B; Spencer MJ; Nakamura G; Tseng-Ong L; Tidball JG
    Am J Pathol; 2000 May; 156(5):1789-96. PubMed ID: 10793090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy.
    Ferrer A; Wells KE; Wells DJ
    Gene Ther; 2000 Sep; 7(17):1439-46. PubMed ID: 11001363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune evasion by muscle-specific gene expression in dystrophic muscle.
    Hartigan-O'Connor D; Kirk CJ; Crawford R; Mulé JJ; Chamberlain JS
    Mol Ther; 2001 Dec; 4(6):525-33. PubMed ID: 11735336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
    Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
    Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective T-lymphocyte migration to muscles in dystrophin-deficient mice.
    Cascabulho CM; Bani Corrêa C; Cotta-de-Almeida V; Henriques-Pons A
    Am J Pathol; 2012 Aug; 181(2):593-604. PubMed ID: 22733008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
    Hodgetts S; Radley H; Davies M; Grounds MD
    Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
    Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
    Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
    J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.